{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T21:49:41Z","timestamp":1791409781512,"version":"4.3.3"},"reference-count":53,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82404539"],"award-info":[{"award-number":["82404539"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005046","name":"Heilongjiang Province Natural Science Foundation","doi-asserted-by":"publisher","award":["LH2024H024"],"award-info":[{"award-number":["LH2024H024"]}],"id":[{"id":"10.13039\/501100005046","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Bioorganic Chemistry"],"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1016\/j.bioorg.2026.110344","type":"journal-article","created":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T23:33:03Z","timestamp":1786059183000},"page":"110344","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Prenylated 4-Hydroxycoumarin derivatives as inducers of CDK4\/6-mediated cell cycle arrest: From design and synthesis to in vitro and in vivo evaluation of their anti-breast Cancer activity"],"prefix":"10.1016","volume":"181","author":[{"given":"Xinyao","family":"Pan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shiyu","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kaifeng","family":"Lai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongbo","family":"Dong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kexin","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yao","family":"Shen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ajiao","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Congcong","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chunli","family":"Gan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bioorg.2026.110344_bb0005","article-title":"Big data in breast cancer: towards precision treatment","volume":"10","author":"Zhang","year":"2024","journal-title":"Digit. Health"},{"issue":"17","key":"10.1016\/j.bioorg.2026.110344_bb0010","doi-asserted-by":"crossref","first-page":"2761","DOI":"10.1158\/0008-5472.CAN-23-2526","article-title":"Obesity induces temporally regulated alterations in the extracellular matrix that drive breast tumor invasion and metastasis","volume":"84","author":"Conner","year":"2024","journal-title":"Cancer Res."},{"issue":"5","key":"10.1016\/j.bioorg.2026.110344_bb0015","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1056\/NEJMoa2005936","article-title":"A population-based study of genes previously implicated in breast Cancer","volume":"384","author":"Hu","year":"2021","journal-title":"N. Engl. J. Med."},{"issue":"2","key":"10.1016\/j.bioorg.2026.110344_bb0020","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1158\/2159-8290.CD-18-1177","article-title":"Insights into molecular classifications of triple-negative breast Cancer: improving patient selection for treatment","volume":"9","author":"Garrido-Castro","year":"2019","journal-title":"Cancer Discov."},{"issue":"1","key":"10.1016\/j.bioorg.2026.110344_bb0025","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1158\/2159-8290.CD-21-1059","article-title":"Hallmarks of cancer: new dimensions","volume":"12","author":"Hanahan","year":"2022","journal-title":"Cancer Discov."},{"key":"10.1016\/j.bioorg.2026.110344_bb0030","doi-asserted-by":"crossref","DOI":"10.1038\/s12276-025-01395-3","article-title":"Targeting CDK4\/6 in breast cancer","author":"Shanabag Anusha","year":"2025","journal-title":"Exp. Mol. Med."},{"issue":"3","key":"10.1016\/j.bioorg.2026.110344_bb0035","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1111\/febs.13898","article-title":"Cell cycle proliferation decisions: the impact of single cell analyses","volume":"284","author":"Matson","year":"2017","journal-title":"FEBS J."},{"issue":"3","key":"10.1016\/j.bioorg.2026.110344_bb0040","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1111\/tpj.15567","article-title":"Cell cycle checkpoint control in response to DNA damage by environmental stresses","volume":"109","author":"Pedroza-Garcia","year":"2022","journal-title":"Plant J."},{"issue":"4","key":"10.1016\/j.bioorg.2026.110344_bb0045","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1158\/2159-8290.CD-15-0894","article-title":"Targeting CDK4 and CDK6: from discovery to therapy","volume":"6","author":"Sherr","year":"2016","journal-title":"Cancer Discov."},{"key":"10.1016\/j.bioorg.2026.110344_bb0050","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.humpath.2018.06.024","article-title":"Clinicopathologic characterization of breast carcinomas in patients with non-BRCA germline mutations: results from a single institution\u2019s high-risk population","volume":"82","author":"Meiss","year":"2018","journal-title":"Hum. Pathol."},{"issue":"7418","key":"10.1016\/j.bioorg.2026.110344_bb0055","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1038\/nature11412","article-title":"Comprehensive molecular portraits of human breast tumours","volume":"490","author":"Koboldt","year":"2012","journal-title":"Nature"},{"issue":"2","key":"10.1016\/j.bioorg.2026.110344_bb0060","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1038\/nrd4504","article-title":"The history and future of targeting cyclin-dependent kinases in cancer therapy","volume":"14","author":"Asghar","year":"2015","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.bioorg.2026.110344_bb0065","article-title":"Palbociclib after CDK and endocrine therapy (PACE): a randomized phase II study of fulvestrant, palbociclib, and avelumab for endocrine pre-treated ER+\/HER2- metastatic breast cancer","author":"Mayer Erica","year":"2018","journal-title":"J. Clin. Oncol."},{"issue":"18","key":"10.1016\/j.bioorg.2026.110344_bb0070","doi-asserted-by":"crossref","first-page":"2084","DOI":"10.1200\/JCO-24-01865","article-title":"Second-line endocrine therapy with or without Palbociclib Rechallenge in patients with hormone receptor-positive\/human epidermal growth factor receptor 2-negative advanced breast Cancer: PALMIRA trial","volume":"43","author":"Llombart-Cussac","year":"2025","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.bioorg.2026.110344_bb0075","doi-asserted-by":"crossref","DOI":"10.1200\/JCO.2019.37.15_suppl.1053","article-title":"A large retrospective analysis of CDK 4\/6 inhibitor retreatment in ER+ metastatic breast cancer (MBC)","author":"dos Anjos Carlos","year":"2019","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.bioorg.2026.110344_bb0080","article-title":"Therapeutic benefits of maintaining CDK4\/6 inhibitors and incorporating CDK2 inhibitors beyond progression in breast cancer","author":"Armand","year":"2025","journal-title":"bioRxiv"},{"issue":"6","key":"10.1016\/j.bioorg.2026.110344_bb0085","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1016\/j.freeradbiomed.2009.12.022","article-title":"Reactive oxygen species, cellular redox systems, and apoptosis","volume":"48","author":"Circu","year":"2010","journal-title":"Free Radic. Biol. Med."},{"issue":"1","key":"10.1016\/j.bioorg.2026.110344_bb0090","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1038\/nrm3722","article-title":"Control of apoptosis by the BCL-2 protein family: implications for physiology and therapy","volume":"15","author":"Czabotar","year":"2014","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"10.1016\/j.bioorg.2026.110344_bb0095","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2024.116882","article-title":"Design, synthesis and biological evaluation of plant-derived miliusol derivatives achieve TNBC profound regression in vivo","volume":"279","author":"Zhao","year":"2024","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.bioorg.2026.110344_bb0100","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2019.104605","article-title":"Ferulin C triggers potent PAK1 and p21-mediated anti-tumor effects in breast cancer by inhibiting tubulin polymerization in vitro and in vivo","volume":"152","author":"Yao","year":"2020","journal-title":"Pharmacol. Res."},{"issue":"4","key":"10.1016\/j.bioorg.2026.110344_bb0105","doi-asserted-by":"crossref","first-page":"718","DOI":"10.1007\/s12094-020-02461-0","article-title":"A natural flavonoid, apigenin isolated from Clerodendrum viscosum leaves, induces G2\/M phase cell cycle arrest and apoptosis in MCF-7 cells through the regulation of p53 and caspase-cascade pathway","volume":"23","author":"Shendge","year":"2021","journal-title":"Clin. Transl. Oncol."},{"key":"10.1016\/j.bioorg.2026.110344_bb0110","doi-asserted-by":"crossref","DOI":"10.1016\/j.phymed.2024.155600","article-title":"Natural products and derivatives for breast cancer treatment: from drug discovery to molecular mechanism","volume":"129","author":"Zhang","year":"2024","journal-title":"Phytomedicine"},{"issue":"1","key":"10.1016\/j.bioorg.2026.110344_bb0115","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/j.canlet.2014.11.017","article-title":"Piperine inhibits the growth and motility of triple-negative breast cancer cells","volume":"357","author":"Greenshields","year":"2015","journal-title":"Cancer Lett."},{"key":"10.1016\/j.bioorg.2026.110344_bb0120","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1016\/j.ejmech.2015.07.010","article-title":"Coumarins as anticancer agents: a review on synthetic strategies, mechanism of action and SAR studies","volume":"101","author":"Thakur","year":"2015","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.bioorg.2026.110344_bb0125","article-title":"Recent advances in 4-hydroxycoumarin chemistry. Part 1: synthesis and reactions","author":"Abdou Moaz","year":"2019","journal-title":"Arab. J. Chem."},{"key":"10.1016\/j.bioorg.2026.110344_bb0130","article-title":"Design, synthesis and biological evaluation of coumarin derivatives as potential BRD4 inhibitors","author":"Cui","year":"2022","journal-title":"Bioorg. Chem."},{"issue":"13","key":"10.1016\/j.bioorg.2026.110344_bb0135","doi-asserted-by":"crossref","first-page":"9328","DOI":"10.1021\/acs.jmedchem.2c00608","article-title":"Novel hybrids of 3-substituted Coumarin and Phenylsulfonylfuroxan as potent antitumor agents with collateral sensitivity against MCF-7\/ADR","volume":"65","author":"Yu","year":"2022","journal-title":"J. Med. Chem."},{"issue":"8","key":"10.1016\/j.bioorg.2026.110344_bb0140","doi-asserted-by":"crossref","first-page":"1303","DOI":"10.1039\/D5NP00011D","article-title":"Prenylated bacterial natural products: occurrence, chemical diversity, biosynthesis and bioactivity","volume":"42","author":"Zhang","year":"2025","journal-title":"Nat. Prod. Rep."},{"issue":"5","key":"10.1016\/j.bioorg.2026.110344_bb0145","doi-asserted-by":"crossref","first-page":"2211","DOI":"10.1021\/acs.jafc.2c07287","article-title":"Prenylation: a critical step for biomanufacturing of Prenylated aromatic natural products","volume":"71","author":"An","year":"2023","journal-title":"J. Agric. Food Chem."},{"issue":"20","key":"10.1016\/j.bioorg.2026.110344_bb0150","doi-asserted-by":"crossref","first-page":"3714","DOI":"10.1021\/jm000942e","article-title":"Fast calculation of molecular polar surface area as a sum of fragment-based contributions and its application to the prediction of drug transport properties","volume":"43","author":"Ertl","year":"2000","journal-title":"J. Med. Chem."},{"issue":"1\u20133","key":"10.1016\/j.bioorg.2026.110344_bb0155","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/S0169-409X(00)00129-0","article-title":"Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings","volume":"46","author":"Lipinski","year":"2001","journal-title":"Adv. Drug Deliv. Rev."},{"issue":"19","key":"10.1016\/j.bioorg.2026.110344_bb0160","doi-asserted-by":"crossref","first-page":"8825","DOI":"10.1021\/acs.jmedchem.8b01005","article-title":"Validation of matrix Metalloproteinase-9 (MMP-9) as a novel target for treatment of diabetic foot ulcers in humans and discovery of a potent and selective small-molecule MMP-9 inhibitor that accelerates healing","volume":"61","author":"Nguyen","year":"2018","journal-title":"J. Med. Chem."},{"issue":"11","key":"10.1016\/j.bioorg.2026.110344_bb0165","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0259691","article-title":"Computational and structural based approach to identify malignant nonsynonymous single nucleotide polymorphisms associated with CDK4 gene","volume":"16","author":"Islam","year":"2021","journal-title":"PloS One"},{"issue":"4","key":"10.1016\/j.bioorg.2026.110344_bb0170","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1007\/s12247-026-10615-w","article-title":"Benzimidazole derivative as a promising targeted therapeutic for lung cancer: in-silico approaches","volume":"21","author":"Miah Roney","year":"2026","journal-title":"J. Pharm. Innov."},{"issue":"1","key":"10.1016\/j.bioorg.2026.110344_bb0175","doi-asserted-by":"crossref","first-page":"25387","DOI":"10.1038\/s41598-025-10744-1","article-title":"Identification and evaluation of pyrimidine based CDK6 inhibitors against glioblastoma using integrated computational approaches","volume":"15","author":"Manzoor","year":"2025","journal-title":"Sci. Rep."},{"issue":"23","key":"10.1016\/j.bioorg.2026.110344_bb0180","doi-asserted-by":"crossref","DOI":"10.3390\/ijms242316990","article-title":"Discovery of GABA aminotransferase inhibitors via molecular docking, molecular dynamic simulation, and biological evaluation","volume":"24","author":"Yasir","year":"2023","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.bioorg.2026.110344_bb0185","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2024.116812","article-title":"Discovery of potent LRRK2 inhibitors by ensemble virtual screening strategy and bioactivity evaluation","volume":"279","author":"Gong","year":"2024","journal-title":"Eur. J. Med. Chem."},{"issue":"7658","key":"10.1016\/j.bioorg.2026.110344_bb0190","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1038\/nature22797","article-title":"The metabolic function of cyclin D3\u2013CDK6 kinase in cancer cell survival","volume":"546","author":"Wang","year":"2017","journal-title":"Nature"},{"issue":"6577","key":"10.1016\/j.bioorg.2026.110344_bb0195","doi-asserted-by":"crossref","DOI":"10.1126\/science.abc1495","article-title":"CDK4 and CDK6 kinases: from basic science to cancer therapy","volume":"375","author":"Fassl","year":"2026","journal-title":"Science"},{"issue":"5","key":"10.1016\/j.bioorg.2026.110344_bb0200","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1016\/j.celrep.2015.12.094","article-title":"Metabolic reprogramming of pancreatic Cancer mediated by CDK4\/6 inhibition elicits unique vulnerabilities","volume":"14","author":"Franco","year":"2016","journal-title":"Cell Rep."},{"issue":"14","key":"10.1016\/j.bioorg.2026.110344_bb0205","doi-asserted-by":"crossref","first-page":"14223","DOI":"10.1021\/acs.jmedchem.3c00955","article-title":"Development of antitumor drugs targeting c-MYC Pu27 and KRAS G-quadruplexes","volume":"68","author":"Mohamed Hany","year":"2025","journal-title":"J. Med. Chem."},{"issue":"9","key":"10.1016\/j.bioorg.2026.110344_bb0210","doi-asserted-by":"crossref","first-page":"7088","DOI":"10.1021\/acs.jmedchem.3c02432","volume":"67","author":"Xu","year":"2024","journal-title":"J. Med. Chem."},{"issue":"D1","key":"10.1016\/j.bioorg.2026.110344_bb0215","doi-asserted-by":"crossref","first-page":"D1670","DOI":"10.1093\/nar\/gkae973","article-title":"Generic diagramming platform (GDP): a comprehensive database of high-quality biomedical graphics","volume":"53","author":"Jiang","year":"2025","journal-title":"Nucleic Acids Res."},{"issue":"19","key":"10.1016\/j.bioorg.2026.110344_bb0220","doi-asserted-by":"crossref","first-page":"1947","DOI":"10.2174\/1568026615666150515145733","article-title":"RNA G-Quadruplex: the new potential targets for therapy","volume":"15","author":"Wang","year":"2015","journal-title":"Curr. Top. Med. Chem."},{"issue":"8","key":"10.1016\/j.bioorg.2026.110344_bb0225","doi-asserted-by":"crossref","first-page":"3891","DOI":"10.1021\/acs.jcim.1c00203","article-title":"AutoDock Vina 1.2.0: new docking methods, expanded force field, and Python bindings","volume":"61","author":"Eberhardt","year":"2021","journal-title":"J. Chem. Inf. Model."},{"issue":"W1","key":"10.1016\/j.bioorg.2026.110344_bb0230","doi-asserted-by":"crossref","first-page":"W530","DOI":"10.1093\/nar\/gkab294","article-title":"PLIP 2021: expanding the scope of the protein-ligand interaction profiler to DNA and RNA","volume":"49","author":"Adasme","year":"2021","journal-title":"Nucleic Acids Res."},{"issue":"5","key":"10.1016\/j.bioorg.2026.110344_bb0235","doi-asserted-by":"crossref","first-page":"3390","DOI":"10.1021\/acs.jctc.8b01231","article-title":"Efficient ensemble refinement by reweighting","volume":"15","author":"K\u00f6finger","year":"2019","journal-title":"J. Chem. Theory Comput."},{"key":"10.1016\/j.bioorg.2026.110344_bb0240","doi-asserted-by":"crossref","DOI":"10.1016\/j.compbiomed.2022.105668","article-title":"Computational investigation of benzalacetophenone derivatives against SARS-CoV-2 as potential multi-target bioactive compounds","volume":"146","author":"Khanal","year":"2022","journal-title":"Comput. Biol. Med."},{"key":"10.1016\/j.bioorg.2026.110344_bb0245","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2021.105392","article-title":"Panaxadiol as a major metabolite of AD-1 can significantly inhibit the proliferation and migration of breast cancer cells: in vitro and in vivo study","volume":"116","author":"Xu","year":"2021","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.bioorg.2026.110344_bb0250","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2025.108307","article-title":"Design, synthesis and antitumor activity evaluation of novel modified 18\u03b2-glycyrrhetinate derivatives as PPAR\u03b3 agonists","volume":"157","author":"Lin","year":"2025","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.bioorg.2026.110344_bb0255","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2024.107808","article-title":"Discovery of flavonoid-containing compound Lupalbigenin as anti-NSCLC cancer agents via suppression of EGFR and ERK1\/2 pathway","volume":"153","author":"Cuan","year":"2024","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.bioorg.2026.110344_bb0260","doi-asserted-by":"crossref","DOI":"10.1021\/acs.jmedchem.2c00947","article-title":"Discovery, optimization, and evaluation of selective CDK4\/6 inhibitors for the treatment of breast cancer","author":"Chen","year":"2022","journal-title":"J. Med. Chem."},{"issue":"11","key":"10.1016\/j.bioorg.2026.110344_bb0265","doi-asserted-by":"crossref","first-page":"7993","DOI":"10.1021\/acs.jmedchem.2c00525","article-title":"Discovery of novel bicyclic Phenylselenyl-containing hybrids: An orally bioavailable, potential, and multiacting class of estrogen receptor modulators against endocrine-resistant breast Cancer","volume":"65","author":"Deng","year":"2022","journal-title":"J. Med. Chem."}],"container-title":["Bioorganic Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0045206826008801?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0045206826008801?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T20:57:09Z","timestamp":1791406629000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0045206826008801"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10]]},"references-count":53,"alternative-id":["S0045206826008801"],"URL":"https:\/\/doi.org\/10.1016\/j.bioorg.2026.110344","relation":{},"ISSN":["0045-2068"],"issn-type":[{"value":"0045-2068","type":"print"}],"subject":[],"published":{"date-parts":[[2026,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Prenylated 4-Hydroxycoumarin derivatives as inducers of CDK4\/6-mediated cell cycle arrest: From design and synthesis to in vitro and in vivo evaluation of their anti-breast Cancer activity","name":"articletitle","label":"Article Title"},{"value":"Bioorganic Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bioorg.2026.110344","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"110344"}}